Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

0.7556

+0.0220 (3.00%)

At close: Aug 14, 2026, 4:00 PM EDT

0.6801

-0.0755 (-9.99%)

After-hours: Aug 14, 2026, 7:58 PM EDT

Citius Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	4.59	4.25	3.25	26.48	41.71	70.07
Cash & Short-Term Investments	4.59	4.25	3.25	26.48	41.71	70.07
Cash Growth	17280.44%	30.76%	-87.72%	-36.51%	-40.47%	405.59%
Receivables	1.08	-	-	-	-	-
Inventory	22.66	22.29	8.27	-	-	-
Prepaid Expenses	3.36	1.4	2.7	7.89	2.85	2.74
Total Current Assets	31.69	27.93	14.22	34.37	44.56	72.81
Property, Plant & Equipment	0.79	0.82	0.25	0.46	0.65	0.83
Goodwill	9.35	9.35	9.35	9.35	9.35	9.35
Other Intangible Assets	90.51	92.8	92.8	59.4	59.4	59.4
Long-Term Deferred Charges	0.17	-	-	-	-	-
Other Long-Term Assets	0.04	0.04	0.04	0.04	0.04	0.04
Total Assets	132.54	130.94	116.65	103.61	114	142.43

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Accounts Payable	9.45	13.69	4.93	2.93	1.17	1.28
Accrued Expenses	27.74	7.48	2.25	2.63	3.17	2.53
Short-Term Debt	-	1	-	-	-	-
Current Portion of Leases	0.17	0.09	0.24	0.22	0.2	0.18
Other Current Liabilities	17.65	22.65	28.4	-	-	-
Total Current Liabilities	55.02	44.91	35.81	5.78	4.53	3.98
Long-Term Leases	0.64	0.72	0.02	0.26	0.48	0.68
Long-Term Deferred Tax Liabilities	7.8	7.77	6.71	6.14	5.56	4.99
Total Liabilities	63.46	53.41	42.55	12.18	10.57	9.65

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Common Stock	0.02	0.02	0.01	0.01	0.15	0.15
Additional Paid-In Capital	329.78	306.34	271.44	253.06	232.37	228.08
Retained Earnings	-268.26	-238.8	-201.37	-162.23	-129.69	-96.05
Total Common Equity	61.54	67.55	70.08	90.83	102.83	132.18
Minority Interest	7.54	9.98	4.02	0.6	0.6	0.6
Shareholders' Equity	69.08	77.53	74.1	91.43	103.43	132.78
Total Liabilities & Equity	132.54	130.94	116.65	103.61	114	142.43

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Total Debt	0.81	1.81	0.26	0.48	0.68	0.86
Net Cash (Debt)	3.78	2.44	2.99	26	41.03	69.22
Net Cash Growth	-	-18.40%	-88.50%	-36.64%	-40.72%	453.40%
Net Cash Per Share	0.21	0.22	0.44	4.30	7.02	15.93
Filing Date Shares Outstanding	27.45	20.76	7.73	6.36	5.85	5.84
Total Common Shares Outstanding	22.38	18.07	7.25	6.35	5.85	5.84
Working Capital	-23.33	-16.98	-21.59	28.59	40.03	68.83
Book Value Per Share	2.75	3.74	9.67	14.29	17.58	22.64
Tangible Book Value	-38.31	-34.6	-32.07	22.08	34.08	63.44
Tangible Book Value Per Share	-1.71	-1.91	-4.43	3.48	5.83	10.86

SEC Filings: 10-K · 10-Q